Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Nov;81(5):783–789. doi: 10.1038/sj.bjc.6690764

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

J C Taylor 1, D R Ferry 2, C F Higgins 3, R Callaghan 1
PMCID: PMC2374293  PMID: 10555746

Abstract

The gene encoding the multidrug resistance P-glycoprotein (P-gp) is duplicated in rodent species and the functional basis for this remains unresolved. Despite a high sequence similarity, the mouse P-gp1a and P-gp1b isoforms show distinct patterns of tissue distribution which suggest a specific role of the P-gp1b isoform in steroid transport. In the present study possible biochemical differences between the isoforms were directly investigated at the level of drug interaction. There was no detectable difference in the affinity or binding capacity of the two isoforms towards [3H]vinblastine at equilibrium. Similarly, the rate at which [3H]vinblastine associates with P-gp was indistinguishable between the two isoforms. Some modest differences were observed in the relative abilities of the multidrug-resistant (MDR) reversing agents CP100-356, nicardipine and verapamil to displace equilibrium [3H]vinblastine binding to P-gp1a and P-gp1b. The steroid hormone progesterone displayed a low affinity (Ki = 1.2 ± 0.2 μM for P-gp1a and 3.5 ± 0.5 μM for P-gp1b), suggesting an unlikely role as a physiological substrate. Thus the mouse isoforms do not appear to exhibit functional differences at the level of initial substrate interaction with protein. © 1999 Cancer Research Campaign

Keywords: P-glycoprotein, MDR, drug binding, steroid hormones

Full Text

The Full Text of this article is available as a PDF (98.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altuvia S., Stein W. D., Goldenberg S., Kane S. E., Pastan I., Gottesman M. M. Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr gene expression. J Biol Chem. 1993 Dec 25;268(36):27127–27132. [PubMed] [Google Scholar]
  2. Arceci R. J., Croop J. M., Horwitz S. B., Housman D. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4350–4354. doi: 10.1073/pnas.85.12.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ayesh S., Shao Y. M., Stein W. D. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim Biophys Acta. 1996 May 24;1316(1):8–18. doi: 10.1016/0925-4439(96)00008-7. [DOI] [PubMed] [Google Scholar]
  4. Barnes K. M., Dickstein B., Cutler G. B., Jr, Fojo T., Bates S. E. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry. 1996 Apr 16;35(15):4820–4827. doi: 10.1021/bi952380k. [DOI] [PubMed] [Google Scholar]
  5. Croop J. M., Raymond M., Haber D., Devault A., Arceci R. J., Gros P., Housman D. E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol. 1989 Mar;9(3):1346–1350. doi: 10.1128/mcb.9.3.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  7. Devault A., Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol. 1990 Apr;10(4):1652–1663. doi: 10.1128/mcb.10.4.1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ferry D. R., Malkhandi P. J., Russell M. A., Kerr D. J. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. Biochem Pharmacol. 1995 Jun 16;49(12):1851–1861. doi: 10.1016/0006-2952(94)00517-p. [DOI] [PubMed] [Google Scholar]
  9. Ferry D. R., Russell M. A., Cullen M. H. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. Biochem Biophys Res Commun. 1992 Oct 15;188(1):440–445. doi: 10.1016/0006-291x(92)92404-l. [DOI] [PubMed] [Google Scholar]
  10. Garrigos M., Mir L. M., Orlowski S. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Eur J Biochem. 1997 Mar 1;244(2):664–673. doi: 10.1111/j.1432-1033.1997.00664.x. [DOI] [PubMed] [Google Scholar]
  11. Georges E., Bradley G., Gariepy J., Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci U S A. 1990 Jan;87(1):152–156. doi: 10.1073/pnas.87.1.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gill D. R., Hyde S. C., Higgins C. F., Valverde M. A., Mintenig G. M., Sepúlveda F. V. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell. 1992 Oct 2;71(1):23–32. doi: 10.1016/0092-8674(92)90263-c. [DOI] [PubMed] [Google Scholar]
  13. Gottesman M. M., Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 1988 Sep 5;263(25):12163–12166. [PubMed] [Google Scholar]
  14. Gros P., Croop J., Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 1986 Nov 7;47(3):371–380. doi: 10.1016/0092-8674(86)90594-5. [DOI] [PubMed] [Google Scholar]
  15. Hardy S. P., Goodfellow H. R., Valverde M. A., Gill D. R., Sepúlveda V., Higgins C. F. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J. 1995 Jan 3;14(1):68–75. doi: 10.1002/j.1460-2075.1995.tb06976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kajiji S., Dreslin J. A., Grizzuti K., Gros P. Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine939/941. Biochemistry. 1994 May 3;33(17):5041–5048. doi: 10.1021/bi00183a006. [DOI] [PubMed] [Google Scholar]
  17. Kajiji S., Talbot F., Grizzuti K., Van Dyke-Phillips V., Agresti M., Safa A. R., Gros P. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry. 1993 Apr 27;32(16):4185–4194. doi: 10.1021/bi00067a005. [DOI] [PubMed] [Google Scholar]
  18. Lever J. E. Active amino acid transport in plasma membrane vesicles from Simian virus 40-transformed mouse fibroblasts. Characteristics of electrochemical Na+ gradient-stimulated uptake. J Biol Chem. 1977 Mar 25;252(6):1990–1997. [PubMed] [Google Scholar]
  19. Malkhandi J., Ferry D. R., Boer R., Gekeler V., Ise W., Kerr D. J. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. Eur J Pharmacol. 1994 Dec 15;288(1):105–114. doi: 10.1016/0922-4106(94)90015-9. [DOI] [PubMed] [Google Scholar]
  20. Orlowski S., Mir L. M., Belehradek J., Jr, Garrigos M. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J. 1996 Jul 15;317(Pt 2):515–522. doi: 10.1042/bj3170515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Piekarz R. L., Cohen D., Horwitz S. B. Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem. 1993 Apr 15;268(11):7613–7616. [PubMed] [Google Scholar]
  22. Spoelstra E. C., Westerhoff H. V., Dekker H., Lankelma J. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Eur J Biochem. 1992 Jul 15;207(2):567–579. doi: 10.1111/j.1432-1033.1992.tb17083.x. [DOI] [PubMed] [Google Scholar]
  23. Tang-Wai D. F., Kajiji S., DiCapua F., de Graaf D., Roninson I. B., Gros P. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry. 1995 Jan 10;34(1):32–39. doi: 10.1021/bi00001a005. [DOI] [PubMed] [Google Scholar]
  24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Trezise A. E., Romano P. R., Gill D. R., Hyde S. C., Sepúlveda F. V., Buchwald M., Higgins C. F. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 1992 Dec;11(12):4291–4303. doi: 10.1002/j.1460-2075.1992.tb05528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem. 1992 Dec 5;267(34):24248–24252. [PubMed] [Google Scholar]
  27. Valverde M. A., Bond T. D., Hardy S. P., Taylor J. C., Higgins C. F., Altamirano J., Alvarez-Leefmans F. J. The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J. 1996 Sep 2;15(17):4460–4468. [PMC free article] [PubMed] [Google Scholar]
  28. Yang C. P., Cohen D., Greenberger L. M., Hsu S. I., Horwitz S. B. Differential transport properties of two mdr gene products are distinguished by progesterone. J Biol Chem. 1990 Jun 25;265(18):10282–10288. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES